Literature DB >> 12228907

Stem-like cells in hepatoblastoma.

Peter Ruck1, Jia-Cheng Xiao.   

Abstract

BACKGROUND: The principles of tumor biology suggest that hepatoblastoma is derived from a pluripotent stem cell. Our studies were undertaken to investigate this tumor for the presence of cells with morphologic and immunophenotypic features of the oval cells of rodents that are thought to be closely related to hepatic stem cells. PROCEDURE: Hepatoblastomas of various subtypes were investigated by electron microscopy and immunoelectron microscopy with antibodies against cytokeratin 7, in the liver a marker of biliary differentiation, and albumin, a marker of hepatocytic differentiation. Immunohistochemical investigations were performed with the antibodies OV-1 and OV-6, which recognize antigens associated with oval cells.
RESULTS: OV-1 stained scattered cells in seven of 12 tumors investigated and OV-6 in nine. Small epithelial cells (SEC) with the ultrastructural features of the oval cells were found by electron microscopy. They were characterized by small size (7-18 microm), often an oval shape, tonofilament bundles, and tight junctions or desmosome-like junctions. SEC were found in small numbers in areas of fetal differentiation and in moderate numbers in areas of embryonal differentiation. In small cell hepatoblastoma, nearly all the tumor cells exhibited SEC-like features. Immunoelectron microscopy revealed coexpression of cytokeratin 7 and albumin by SEC.
CONCLUSIONS: SEC with ultrastructural and immunophenotypic features exhibited by oval cells, i.e., hepatic stem-like cells, are found in hepatoblastoma. Their numbers vary with the differing degrees of differentiation seen in the various subtypes. The findings further support the hypothesis that hepatoblastoma is derived from a pluripotent stem cell. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12228907     DOI: 10.1002/mpo.10175

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  5 in total

1.  Hepatic progenitor cells in human liver cirrhosis: immunohistochemical, electron microscopic and immunofluorencence confocal microscopic findings.

Authors:  Jia-Cheng Xiao; Xiao-Long Jin; Peter Ruck; Anne Adam; Edwin Kaiserling
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

2.  CITED1 expression in liver development and hepatoblastoma.

Authors:  Andrew J Murphy; Christian de Caestecker; Janene Pierce; Scott C Boyle; Gregory D Ayers; Zhiguo Zhao; Jaime M Libes; Hernan Correa; Teagan Walter; Stacey S Huppert; Alan O Perantoni; Mark P de Caestecker; Harold N Lovvorn
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

3.  Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization.

Authors:  Xia Qian; Wei Zhang; Alireza Shams; Kahee Mohammed; Alex S Befeler; Ningling Kang; Jinping Lai
Journal:  Liver Res       Date:  2020-11-08

4.  Co-Expression of CD34, CD90, OV-6 and Cell-Surface Vimentin Defines Cancer Stem Cells of Hepatoblastoma, Which Are Affected by Hsp90 Inhibitor 17-AAG.

Authors:  Mieun Lee-Theilen; Julia R Hadhoud; Giulietta Volante; Delaine D Fadini; Julia Eichhorn; Udo Rolle; Henning C Fiegel
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

Review 5.  The Emerging Roles of Cancer Stem Cells and Wnt/Beta-Catenin Signaling in Hepatoblastoma.

Authors:  Nirmala Mavila; Jyothi Thundimadathil
Journal:  Cancers (Basel)       Date:  2019-09-20       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.